SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,504.75 |
| Enterprise Value ($M) | 4,109.98 |
| Book Value ($M) | -185.76 |
| Book Value / Share | -2.34 |
| Price / Book | -18.87 |
| NCAV ($M) | -813.97 |
| NCAV / Share | -10.27 |
| Price / NCAV | -4.31 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.23 |
| Return on Assets (ROA) | 0.33 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 156.28 |
| Current Ratio | 157.97 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,027.18 |
| Assets | 2,655.39 |
| Liabilities | 2,841.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 806.78 |
| Operating Income | -146.75 |
| Net Income | -363.30 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -107.69 |
| Cash from Investing | 44.18 |
| Cash from Financing | 255.87 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 8.00 | -18.18 | |
| 13G/A | Camber Capital Management LP | 4.15 | ||
| 13G/A | Armistice Capital, Llc | 8.27 | -11.84 | |
| 13G/A | Wellington Management Group Llp | 6.20 | -39.35 | |
| 13G/A | State Street Corp | 3.80 | -37.44 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 176,686 | 1,268,979 | 13.92 | |
| 305,915 | 1,492,643 | 20.49 | |
| 370,907 | 2,681,206 | 13.83 | |
| 605,808 | 3,824,785 | 15.84 | |
| 542,081 | 3,903,743 | 13.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRAX – Praxis Precision Medicines, Inc. | PRLD – Prelude Therapeutics Incorporated |
| PRTA – Prothena Corporation plc | PYXS – Pyxis Oncology, Inc. |
| QDEL – QuidelOrtho Corporation |
Financial data and stock pages provided by
Fintel.io